Discordant low-gradient aortic stenosis: a phenotype-first, likelihood-tiered multimodality imaging framework

Discordant low-gradient aortic stenosis (AS), commonly defined by the aortic valve area (AVA) ≤1.0 cm 2 with mean gradient <40 mmHg and peak velocity <4.0 m/s, is reported in up to 40% of patients evaluated for AS in selected cohorts. Current guidelines and consensus documents outline echocardiographic quality control, haemodynamic phenotype assignment, dobutamine stress echocardiography (DSE), CT aortic valve calcium scoring (CT-AVC), and integrated assessment, yet uncertainty persists when haemodynamic, structural, symptomatic, and myocardial findings diverge. This narrative review proposes a phenotype-first, likelihood-tiered multimodality framework that adds four operational elements to current guidance: routine documentation of transvalvular flow rate, phenotype-specific interpretation of DSE and CT-AVC, separation of valve severity adjudication from myocardial risk refinement, and structured reporting of residual uncertainty. DSE with projected AVA is favoured for flow-dependent severity assessment in classical low-flow low-gradient AS, whereas CT-AVC likelihood categories are emphasised in preserved-ejection-fraction low-gradient phenotypes and after inconclusive DSE. Cardiovascular magnetic resonance, global longitudinal strain, extracellular volume fraction, and cardiac damage staging are used as prognostic and counselling adjuncts, not stand-alone triggers for valve intervention. Indeterminate cases are reported as unresolved discordance with the basis of uncertainty stated explicitly. The approach is intended to improve Heart Team communication and requires prospective validation before use as a treatment algorithm.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-09
DOI
https://doi.org/10.3389/fcvm.2026.1901893
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Discordant low-gradient aortic stenosis: a phenotype-first, likelihood-tiered multimodality imaging framework

Yujian Liu, Xue An, Yuan Li
Frontiers in Cardiovascular Medicine
Cardiac Valve Diseases and Treatments
article

Discordant low-gradient aortic stenosis: a phenotype-first, likelihood-tiered multimodality imaging framework

Yujian Liu, Xue An, Yuan Li
article en

Abstract

Discordant low-gradient aortic stenosis (AS), commonly defined by the aortic valve area (AVA) ≤1.0 cm 2 with mean gradient <40 mmHg and peak velocity <4.0 m/s, is reported in up to 40% of patients evaluated for AS in selected cohorts. Current guidelines and consensus documents outline echocardiographic quality control, haemodynamic phenotype assignment, dobutamine stress echocardiography (DSE), CT aortic valve calcium scoring (CT-AVC), and integrated assessment, yet uncertainty persists when haemodynamic, structural, symptomatic, and myocardial findings diverge. This narrative review proposes a phenotype-first, likelihood-tiered multimodality framework that adds four operational elements to current guidance: routine documentation of transvalvular flow rate, phenotype-specific interpretation of DSE and CT-AVC, separation of valve severity adjudication from myocardial risk refinement, and structured reporting of residual uncertainty. DSE with projected AVA is favoured for flow-dependent severity assessment in classical low-flow low-gradient AS, whereas CT-AVC likelihood categories are emphasised in preserved-ejection-fraction low-gradient phenotypes and after inconclusive DSE. Cardiovascular magnetic resonance, global longitudinal strain, extracellular volume fraction, and cardiac damage staging are used as prognostic and counselling adjuncts, not stand-alone triggers for valve intervention. Indeterminate cases are reported as unresolved discordance with the basis of uncertainty stated explicitly. The approach is intended to improve Heart Team communication and requires prospective validation before use as a treatment algorithm.

Frontiers in Cardiovascular MedicineVol. 13
Zigong First People's Hospital (CN)
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon